Veris Residential (VRE) Form 144 Reports 30,592-Share Sale on NYSE

Rhea-AI Filing Summary

Form 144 filing for Veris Residential, Inc. (VRE) reports a proposed open-market sale of 30,592 common shares through Morgan Stanley Smith Barney with an aggregate market value of $473,157.29, targeting an approximate sale date of 09/18/2025 on the NYSE. The filer acquired these shares via an open-market purchase on 07/25/2018 and paid cash. The filing also lists multiple recent sales by affiliated entities on dates from 09/09/2025 to 09/17/2025, with individual gross proceeds ranging from approximately $232,632 to $1,846,956. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Complete transaction disclosure including acquisition date, payment method, broker, and planned sale date
• Detailed history of recent sales by affiliated entities with amounts and gross proceeds, improving transparency

Negative

• Multiple large affiliate sales across several days could be perceived as notable selling pressure (disclosed amounts up to ~$1.85M)
• No 10b5-1 plan adoption date or additional context provided about the reason for the sales in the filing

Insights

Financial Analyst

TL;DR: Proposed sale is modest in value relative to institutional trades, but recent multiple-day disposals indicate active selling from affiliated entities.

The filing documents a planned sale of 30,592 shares valued at $473,157.29 executed through Morgan Stanley Smith Barney and acquired in 2018 by open-market purchase. The schedule of prior sales shows substantial daily disposals across two affiliated entities from 09/09/2025 to 09/17/2025 with gross proceeds per day up to roughly $1.85 million, indicating liquidity events rather than an isolated small transfer. For investors, these are disclosures of insider/affiliate selling activity without commentary on company operations. Impact rating: 0 (neutral) because the filing reports disposition activity but contains no operational or financial performance information.

Corporate Governance Expert

TL;DR: Form 144 properly discloses proposed and recent sales; representations about absence of undisclosed material information are standard and present.

The notice provides required details: acquisition date (07/25/2018), method (open market), payment (cash), broker details, and dates/amounts of recent affiliate sales. Signature and attestation language regarding material adverse information and 10b5-1 plans are included but no plan adoption date is stated. This is a routine compliance disclosure documenting insider/affiliate securities sales. Impact rating: 0 (neutral) since it meets disclosure requirements and contains no governance concerns beyond routine selling.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	30592	473157.29	93421769	09/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/25/2018	Open Market Purchase	Open Market			30592	07/25/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/17/2025	14989	232632.28
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/17/2025	20097	311909.46
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/16/2025	40355	622601.54
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/16/2025	54108	834784.42
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/15/2025	26600	416276.70
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/15/2025	19838	310454.78
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/12/2025	79724	1272734.52
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/12/2025	106897	1706531.26
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	85440	1373003.71
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	114560	1840956.29
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	85920	1378491.89
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	64080	1028093.11
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	64080	1032924.74
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	85920	1384970.29

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the VRE Form 144 disclose about the proposed sale?

The filing discloses a proposed open-market sale of 30,592 common shares valued at $473,157.29 through Morgan Stanley Smith Barney with an approximate sale date of 09/18/2025.

When and how were the shares to be sold acquired according to the filing?

The shares were acquired on 07/25/2018 via an open-market purchase and payment was made in cash on the acquisition date.

Does the filing show any recent sales by affiliated entities?

Yes. The filing lists multiple sales by affiliated entities between 09/09/2025 and 09/17/2025, with individual gross proceeds ranging from about $232,632 to $1,846,956.

Which broker is handling the proposed sale in the Form 144?

The broker named in the filing is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

Does the Form 144 state whether the seller knows of undisclosed material adverse information?

Yes. The signer represents that they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.